Comparative proteomic analysis of human somatic cells, induced pluripotent stem cells, and embryonic stem cells

Stem Cells and Development

Volumn 21, Issue 8, 2012, Pages 1272-1286

  Kim, Sun Young ^a,b   Kim, Min Jeong ^a   Jung, Hyeyun ^a   Kim, Won Kon ^a   Kwon, Sang Oh ^c   Son, Myung Jin ^a   Jang, Ik Soon ^c   Choi, Jong Soon ^c   Park, Sung Goo ^a   Park, Byoung Chul ^a   Han, Yong Mahn ^b   Lee, Sang Chul ^a   Cho, Yee Sook ^a   Bae, Kwang Hee ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEOME; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FIBROBLAST; HUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEOMICS; SOMATIC CELL;

BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; COMPUTATIONAL BIOLOGY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EMBRYONIC STEM CELLS; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFANT, NEWBORN; MALE; MASS SPECTROMETRY; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TISSUE DONORS;

EID: 84861987924     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0243     Document Type: Article

References (46)

1. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676. (Pubitemid 44233629)
2. Winkler J, I Sotiriadou, S Chen, J Hescheler and A Sachinidis. (2009). The potential of embryonic stem cells combined with-omics technologies as model systems for toxicity. Curr Med Chem 16:4814-4827.
3. Jalving M and H Schepers. (2009). Induced pluripotent stem cells: will they be safe? Curr Opin Mol Ther 11:383-393.
4. Smith KP, MX Luong and GS Stein. (2009). Pluripotency: toward a gold standard for human ES and iPS cells. J Cell Physiol 220:21-29.
5. Yamanaka S. (2007). Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1:39-49.
6. Hochedlinger K and K Plath. (2009). Epigenetic reprogramming and induced pluripotency. Development 136:509-523.
7. Daley GQ. (2010). Stem cells: roadmap to the clinic. J Clin Invest 120:8-10.
8. Banito A and J Gil. (2010). Induced pluripotent stem cells and senescence: learning the biology to improve the technology. EMBO Rep 11:353-359.
9. Huangfu D, K Osafune, R Maehr,WGuo, A Eijkelenboom, S Chen, W Muhlestein and DA Melton. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nature Biotechnol 26:1269-1275.
10. Park I-H, R Zhao, JA West, A Yabuuchi, H Huo, TA Ince, PH Lerou, MW Lensch and GQ Daley. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146.
11. Kim JB, B Greber, MJ Arauzo-Bravo, J Meyer, K-I Park, H Zaehres and HR Scholer. Direct reprogramming of human neural stem cells by OCT4. Nature 461:649-654.
12. Brambrink T, R Foreman, GG Welstead, CJ Lengner, M Wernig, H Suh and R Jaenisch. (2008). Sequential expression of pluripotent markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2:151-159. (Pubitemid 351168714)
13. Dihazi H, GH Dihazi, J Nolte, S Meyer, O Jahn, GA Muller and W Engel. (2009). Multipotent adult germline stem cells and embryonic stem cells: comparative proteomic approach. J Proteome Res 8:5497-5510.
14. Rigbolt KT, TA Prokhorova, V Akimov, J Henningsen, PT Johansen, I Kratchmarova, M Kassem, M Mann, JV Olsen and B Blaqoev. (2011). System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal 4:rs3.
15. Wang S, R Tian, D Figeys and L Wang. (2011). An enhanced chemically defined SILAC culture system for quantitative proteomics study of human embryonic stem cells. Proteomics doi:10.1002/pmic.201100052.
16. Graumann J, NC Hubner, JB Kim, K Ko, M Moser, C Kumar, J Cox, H Scholer and M Mann. (2008). Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins. Mol Cell Proteomics 7:672-683. (Pubitemid 351597479)
17. Kim MS, J Kim, HW Han, YS Cho, YM Han and JK Park. (2007). Microfabricated embryonic stem cell divider for large-scale propagation of human embryonic stem cells. Lab Chip 7:513-515. (Pubitemid 46496554)
18. Kang TH, K-H Bae, Mj Yu, WK Kim, H-R Hwang, H Jung, PY Lee, S Kang, T-S Yoon, et al. (2007). Phosphoproteomic analysis of neuronal cell death by glutamate-induced oxidative stress. Proteomics 7:2624-2635. (Pubitemid 47253821)
19. Kim S-Y, PY Lee, H-J Shin, DH Kim, S Kang, H-B Moon, SW Kang, J-M Kim, SG Park, et al. (2009). Proteomic analysis of liver tissue from HBx-transgenic mice at early stages of hepatocarcinogenesis. Proteomics 9:5056-5066.
20. Kang S, EY Kim, JW Chung, T-S Yoon, DH Lee, SG Park, BC Park and K-H Bae. (2007). Proteomic analysis of effect of MAPK pathway activation on L-glutamate-induced neuronal cell death. Cell Mol Biol Lett 12:139-147. (Pubitemid 46786648)
21. Collins GA and WP Tansey. (2006). The proteasome: a utility tool for transcription? Curr Opin Genet Dev 16:197-202. (Pubitemid 43376068)
22. Szutorisz H, A Georgiou, L Tora and N Dillon. (2006). The proteasome restricts permissive transcription at tissue-specific gene loci in embryonic stem cells. Cell 127:1357-1388.
23. Ayoub N, AD Jeyasekharan, JA Bernal and AR Venkitaraman. (2008). HP1-b mobilization promotes chromatin changes that initiate the DNA damage response. Nature 453: 682-686. (Pubitemid 351769293)
24. Rowe HM, J Jakobsson, D Mesnard, J Rougemont, S Reynard, T Aktas, PV Maillard, H Layard-Liesching, S Verp, et al. KAP1 controls endogenous retroviruses in embryonic stem cells. Nature 463:237-240.
25. Djuric U and J Ellis. (2010). Epigenetics of induced pluripotency, the seven-headed dragon. Stem Cell Res 1:3.
26. Hochedlinger K and K Plath. (2009). Epigenetic reprogramming and induced pluripotency. Development 136:509-523.
27. Yosida Y, K Takahashi, K Okita, T Ichisaka and S Yamanaka. (2009). Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5:237-241.
28. Cho YM, S Kwon, YK Park, HW Seol, YM Choi, DJ Park, KS Park and HK Lee. (2006). Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochem Biophys Res Comm 348:1472-1478. (Pubitemid 44291363)
29. Prigione A, B Fauler, R Lurz, H Lehrach and J Adjaye. (2010). The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 28:721-733.
30. Rehman J. (2010). Empowering self-renewal and differentiation: the role of mitochondria in stem cells. J Mol Med 88:981-986.
31. Hara MR, N Agrawal, SF Kim, MB Cascio, M Fujimuro, Y Ozeki, M Takahashi, JH Cheah, SK Tankou, et al. (2005). S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 7:665-674. (Pubitemid 40975747)
32. Tristan C, N Shahani, TW Sedlak and A Sawa. (2011). The diverse functions of GAPDH: Views from different subcellular compartments. Cell Signal 23:317-323.
33. Jang M, HJ Kang, SY Lee, SJ Chung, S Kang, S-W Chi, S Cho, SC Lee, C-K Lee, et al. (2009). Glycerladehyde-3-phosphate, a glycolytic intermediate, plays a key role in controlling cell fate via inhibition of caspase activity. Mol Cells 28:559-563.
34. Sabri N, P Roth, F Xylourgidis, F Sadeghifar, J Adler and C Samakovlis. (2007). Distinct functions of the Drosophila Nup153 and Nup214 FG domains in nuclear protein transport. J Cell Biol 178:557-565. (Pubitemid 47267268)
35. Terry L and S Wente. (2007). Nuclear mRNA export requires specific FG nucleoporins for translocation through the nuclear pore complex. J Cell Biol 178:1121-1132. (Pubitemid 47480221)
36. Lupu F, A Alves, K Anderson, V Doye and E Lacy. (2008). Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo. Dev Cell 14: 831-842. (Pubitemid 351757198)
37. Karetsou Z, G Martic, G Sflomos and T Papamarcaki. (2005). The histone chaperone SET/TAF-Ib interacts functionally with the CREB-binding protein. Biochem Biophys Res Comm 335:322-327. (Pubitemid 41140224)
38. Muto S, M Senda, Y Akai, L Sato, T Suzuki, R Nagai, T Senda and M Horikoshi. (2007). Relationship between the structure of SET/TAF-Ib/INHAT and its histone chaperone activity. Proc Natl Acad Sci 104:4285-4290. (Pubitemid 47186218)
39. Kandilci A, E Mientjes and G Grosveld. (2004). Effects of SET and SET-CAN on the differentiation of the human promonocytic cell line U937. Leukemia 18:337-340. (Pubitemid 38240051)
40. Katagiri T, N Hatano, M Aihara, H Kawano, M Okamoto, Y Liu, T Izumi, T Maekawa, S Nakamura, et al. (2010). Proteomic analysis of proteins expressing in regions of rat brain by a combination of SDS-PAGE with nano-liquid chromatography- quadrupole-time of flight tandem mass spectrometry. Proteome Sci 8:41.
41. Ortiz PA, ME Bruno, T Moore, S Nesnow, W Winnik and Y Ge. (2010). Proteomic analysis of propiconazole responses in mouse liver: comparison of genomic and proteomic profiles. J Proteome Res 9:1268-1278.
42. Wierstra I and J Alves. (2008). The c-myc promoter: still MysterY and challenge. Adv. Cancer Res 99:113-333. (Pubitemid 350137254)
43. Jang M, BC Park, S Kang, S-W Chi, Cho S, SJ Chung, SC Lee, K-H Bae and SG Park. (2009). Far upstream element-binding protein-1, a novel caspase substrate, acts as a cross-talker between apoptosis and the c-myc oncogene. Oncogene 28: 1529-1536.
44. Wernig M, A Meissner, JP Cassady and R Jaenisch. (2008). c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2:10-12.
45. Okita K, M Nakagawa, H Hyenjong, T Ichisaka and S Yamanaka. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science 322: 949-953.
46. Chung H-J, J Liu, M Dundr, Z Nie, S Sanford and D Levens. (2006). FBPs are calibrated molecular tools to adjust gene expression. Mol Cell Biol 26:6584-6597. (Pubitemid 44277896)